Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Total Liabilities (2009 - 2026)

Bio-Techne (TECH) posted quarterly Total Liabilities of $2.6 billion for Q1 2026, down 3.54% year-over-year from $2.6 billion in Q1 2025, and up 1.11% quarter-over-quarter from $2.5 billion in Q4 2025.

Analysis

Bio-Techne (TECH) Total Liabilities (2009 - 2026) Analysis & Trends

Bio-Techne's Total Liabilities history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

  • In Q1 2026, Total Liabilities fell 3.54% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $2.6 billion (down 3.54% YoY), while the FY2025 annual figure was $2.6 billion, down 5.4% from the prior year.
  • Total Liabilities for Q1 2026 stood at $2.6 billion, up from $2.5 billion in the prior quarter.
  • The five-year high for Total Liabilities was $2.8 billion in Q3 2023, with the low at $2.3 billion in Q2 2022.
  • The 5-year median for Total Liabilities is $2.6 billion (2023), against an average of $2.6 billion.
  • The sharpest annual moves came in 2023 and 2025: Total Liabilities advanced 17.21% in 2023, then declined 7.67% in 2025.
  • Bio-Techne's Total Liabilities stood at $2.4 billion in 2022, then advanced by 15.54% to $2.7 billion in 2023, then declined by 2.21% to $2.7 billion in 2024, then fell by 5.53% to $2.5 billion in 2025, then increased by 1.11% to $2.6 billion in 2026.
  • Business Quant data shows TECH's Total Liabilities at $2.6 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn 478.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 478.51 Mn
Mar 31, 2026 465.30 Mn
Dec 31, 2025 511.71 Mn
Sep 30, 2025 560.33 Mn
Jun 30, 2025 639.06 Mn
Mar 31, 2025 626.23 Mn
Dec 31, 2024 591.93 Mn
Sep 30, 2024 597.37 Mn
Jun 30, 2024 635.02 Mn
Mar 31, 2024 706.80 Mn
Dec 31, 2023 767.19 Mn
Sep 30, 2023 757.61 Mn
Jun 30, 2023 672.18 Mn
Mar 31, 2023 710.01 Mn
Dec 31, 2022 536.30 Mn
Sep 30, 2022 599.57 Mn
Jun 30, 2022 593.79 Mn
Mar 31, 2022 586.57 Mn
Dec 31, 2021 602.32 Mn
Sep 30, 2021 623.23 Mn